메뉴 건너뛰기
Blood Coagulation and Fibrinolysis
Volumn 10, Issue SUPPL. 1, 1999, Pages
The Fourth International Symposium on fibrinogen as a vascular risk factor

(1)  Caen, J P a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

EID: 26444434642     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (1)
References (3)
  • 1
    • 0033069414 scopus 로고    scopus 로고
    • Clinical benefit of fibrinogen evaluation
    • Lowe G, Rumley A. Clinical benefit of fibrinogen evaluation. Blood Coag Fibrinol 1999, 10 (suppl 1): S87-S89.
    • (1999) Blood Coag Fibrinol , vol.10 , Issue.1 SUPPL.
    • Lowe, G.1    Rumley, A.2
  • 2
    • 0031839761 scopus 로고    scopus 로고
    • The relative power of heart-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: The Caerphilly and Speedwell studies
    • Sweetnam PM, Yarnell JWG, Lowe GDO, et al. The relative power of heart-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: The Caerphilly and Speedwell studies. Br J Haemat 1998; 100: 582-588.
    • (1998) Br J Haemat , vol.100 , pp. 582-588
    • Sweetnam, P.M.1    Yarnell, J.W.G.2    Lowe, G.D.O.3
  • 3
    • 0024508910 scopus 로고
    • Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA
    • Bahnak BR, Wu QY, Coulombel L, et al. Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol 1989; 138: 305-310.
    • (1989) J Cell Physiol , vol.138 , pp. 305-310
    • Bahnak, B.R.1    Wu, Q.Y.2    Coulombel, L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.